Study guide

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration

Key Takeaways Explain This Topic AI

Define mitral-regurgitation mechanism before grading severity: primary MR is intrinsic leaflet or chordal disease, whereas secondary MR reflects ventricular or atrial remodeling that impairs coaptation of otherwise nonprimary leaflets.

Acquire color, CW, PW, vena-contracta, flow-convergence, pulmonary-vein, chamber, and hemodynamic data in multiple views because every MR measurement has important loading, geometric, and technical limitations.

Use EROA, regurgitant volume, regurgitant fraction, vena contracta, jet behavior, pulmonary-vein flow, and cardiac response as mutually checking evidence rather than interchangeable single-test verdicts.

Investigate discordance by reviewing blood pressure, rhythm, jet number and geometry, acute versus chronic presentation, image settings, and method assumptions; escalate unresolved cases for interpreter-directed TEE or CMR.

Last updated: July 2026

Start with mechanism, not jet size

CCI task C6 requires assessment of mitral regurgitation (MR). First document blood pressure, heart rate, rhythm, symptoms, and whether the presentation appears acute or chronic. Then image the mitral apparatus—annulus, anterior and posterior leaflets, chordae, papillary muscles, LV, and LA—from parasternal long- and short-axis, apical four- and two-chamber, and apical long-axis views. Sweep rather than relying on one frozen plane. Describe visible A1–A3 and P1–P3 segments only when localization is secure; eccentric jet direction can suggest the involved leaflet but does not prove the lesion.

Primary MR results from intrinsic disease such as myxomatous prolapse or flail, chordal rupture, endocarditis with perforation, rheumatic restriction, or cleft. Secondary MR occurs when remodeling prevents coaptation without a primary leaflet lesion. Ventricular secondary MR commonly has LV dilation, papillary displacement, systolic tethering, and annular enlargement. Atrial secondary MR is associated with LA and annular dilation, often atrial fibrillation, with relatively preserved LV geometry and less tethering. Carpentier motion terminology helps connect anatomy to function: type I has normal motion with annular dilation or perforation, type II excessive motion from prolapse or flail, type IIIa restriction in systole and diastole as in rheumatic disease, and type IIIb systolic restriction typical of ventricular secondary MR.

Assemble independent severity evidence

Optimize color gain just below random speckle and use a velocity scale appropriate for detecting the jet without obscuring the convergence region. Save multiple views and cine loops because a wall-hugging eccentric jet may lose momentum through the Coanda effect and look deceptively small. Jet area also varies with gain, scale, driving pressure, LA pressure, and chamber size. A large central mosaic supports important MR only in context; jet area alone does not grade it.

Evidence What to acquire Principal limitation

Valve anatomy Prolapse, flail, restriction, perforation, coaptation gap Shadow, dropout, and off-axis localization

Vena contracta Narrowest neck at or just downstream from the orifice Multiple, noncircular, or dynamic orifices

PISA Radius, aliasing velocity, MR peak velocity, MR VTI in the same state Eccentric, elliptical, multiple, or late-systolic flow

CW Doppler Complete jet envelope, density, contour, timing Velocity reflects pressure difference, not regurgitant volume

Pulmonary veins PW in more than one vein when feasible AF, elevated LA pressure, and sampling location alter flow

Cardiac response LV and LA size/function, pulmonary pressure Acute severe MR may precede dilation

Measure vena-contracta width perpendicular to the jet at the narrowest neck. A width at least 0.7 cm supports severe MR for a single primary jet, but a two-dimensional width can misrepresent an elliptical orifice and cannot simply be added across multiple jets. Three-dimensional vena-contracta area can display complex orifices more directly when spatial and temporal resolution are adequate.

For a suitable hemispheric proximal isovelocity surface area (PISA), shift the color baseline toward the jet to create a measurable convergence shell, then measure the radius from the orifice to the first aliasing boundary. Calculate:

  • EROA = 2πr² × aliasing velocity / peak MR velocity
  • Regurgitant volume = EROA × MR VTI

Use measurements from the same physiologic state and appropriate systolic frame. Hemispheric assumptions often fail with wall constraint, eccentricity, multiple jets, an elliptical secondary-MR orifice, or marked systolic variation. A single mid-systolic PISA may overstate a brief late-systolic prolapse jet or misrepresent dynamic secondary MR.

A volumetric method subtracts forward LVOT stroke volume from total LV stroke volume; regurgitant fraction is regurgitant volume divided by total LV stroke volume. Doppler inflow-versus-outflow methods are vulnerable to annular diameter, sample-position, rhythm, and concomitant regurgitation errors. Three-dimensional LV volumes can reduce geometric assumptions if borders are complete. Audit inputs when a calculated volume conflicts with anatomy or other Doppler findings.

Integrate severity and explain discordance

For chronic primary MR, EROA at least 0.40 cm², regurgitant volume at least 60 mL, regurgitant fraction at least 50%, and vena contracta at least 0.7 cm are standard severe-pattern markers. They are not four automatic diagnoses. Dense triangular early-peaking CW flow, systolic pulmonary-vein flow reversal, a flail leaflet, and appropriate LV/LA response strengthen the conclusion. CW peak velocity alone cannot quantify MR: a low velocity may reflect low systemic pressure or high LA pressure, while a high velocity can accompany a small jet.

Secondary MR often has a crescentic or elliptical orifice, lower forward flow, and dynamic loading, so a circular PISA and primary-MR thresholds can underrepresent or misclassify it. Report the measured values and mechanism, then let the interpreting clinician apply disease-specific context. Acute severe MR may show a small color jet, normal chamber size, low velocity, rapid pressure equalization, and pulmonary edema; absence of chronic dilation is not reassurance.

When findings disagree, verify BP and rhythm, color settings, Doppler alignment, jet multiplicity, PISA geometry, vena-contracta plane, pulmonary-vein placement, and chamber measurements. Reacquire rather than selecting the convenient value. Clearly label nonquantifiable data and communicate flail tissue, suspected endocarditis, acute severe MR, or hemodynamic instability promptly. The interpreter may use TEE for lesion anatomy or CMR for regurgitant volume when a technically adequate TTE still remains discordant.

For serial assessment, reproduce blood pressure, rhythm, color scale, view, and quantitation method; compare source images rather than report labels, because altered afterload or a different vena-contracta/PISA plane can mimic interval change.